Lindberg T, Ohlsson K, Weström B
Pediatr Res. 1982 Jun;16(6):479-83. doi: 10.1203/00006450-198206000-00016.
Protease inhibitors and protease (caseinolytic, elastinolytic and esterolytic) activity were analysed in 190 milk samples from 94 mothers from day 1 to day 160 after delivery. The main protease inhibitors in human milk are alpha 1-antichymotrypsin and alpha 1-antitrypsin. As measured by electroimmunoassay, the level of alpha 1-antichymotrypsin in day 1 colostrum was higher than that in normal serum. Trace amounts of inter-alpha-trypsin inhibitor, alpha 2-antiplasmin, alpha 2-macroglobulin, antithrombin III, or antileukoprotease could be demonstrated. According to their protease inhibiting activity, the 53 milk samples from day 1-3 could be divided into two groups. (1) Presence of protease inhibiting activity (n = 35). Both alpha 1-antitrypsin and alpha 1-antichymotrypsin appeared intact and were able to form complexes with added trypsin or chymotrypsin although the major part of alpha 1-antichymotrypsin showed a retarded electrophoretic mobility. The proteolytic inhibiting activity, in spite of the presence of immunoreactive inhibitors (n = 18). alpha 1-antichymotrypsin had a precipitate pattern similar to group 1, whereas alpha 1-antitrypsin had a major fraction with slightly retarded mobility and two minor peaks in the alpha 1-and beta-regions. These precipitate patterns were unchanged on addition of human trypsin or chymotrypsin compatible with the presence of nonreactive inhibitor only. These samples had a caseinolytic and esterolytic activity with an electrophoretic mobility in the beta-region. All samples from day 4 and later had a demonstrable protease inhibiting activity.
对94位母亲产后第1天至第160天的190份乳汁样本进行了蛋白酶抑制剂和蛋白酶(酪蛋白分解酶、弹性蛋白酶和酯酶)活性分析。人乳中的主要蛋白酶抑制剂是α1-抗糜蛋白酶和α1-抗胰蛋白酶。通过电免疫测定法测量,第1天初乳中α1-抗糜蛋白酶的水平高于正常血清中的水平。可检测到痕量的α-胰蛋白酶抑制剂、α2-抗纤溶酶、α2-巨球蛋白、抗凝血酶III或抗白细胞蛋白酶。根据其蛋白酶抑制活性,第1 - 3天的53份乳汁样本可分为两组。(1)存在蛋白酶抑制活性(n = 35)。α1-抗胰蛋白酶和α1-抗糜蛋白酶均保持完整,并且尽管α1-抗糜蛋白酶的大部分显示出电泳迁移率延迟,但仍能够与添加的胰蛋白酶或糜蛋白酶形成复合物。(2)尽管存在免疫反应性抑制剂(n = 18),但蛋白水解抑制活性仍存在。α1-抗糜蛋白酶的沉淀模式与第1组相似,而α1-抗胰蛋白酶有一个迁移率略有延迟的主要部分以及在α1和β区域的两个小峰。加入人胰蛋白酶或糜蛋白酶后,这些沉淀模式未改变,这与仅存在无反应性抑制剂相符。这些样本具有酪蛋白分解酶和酯酶活性,其电泳迁移率在β区域。第4天及以后的所有样本都具有可检测到的蛋白酶抑制活性。